Uroxatral

Indicated For

Benign prostatic hyperplasia (BPH)

About This Medication

# Otsuka Patient Assistance Foundation (OPAF) Patient Guide: How to Get Uroxatral (alfuzosin) at Low or No Cost Uroxatral (alfuzosin) is a prescription medication used to treat symptoms of an enlarged prostate, known as benign prostatic hyperplasia (BPH), by relaxing muscles in the prostate and bladder neck to improve urine flow. The **Otsuka Patient Assistance Foundation (OPAF)** offers eligible uninsured or underinsured patients free access to Uroxatral through a straightforward application process.[1][5] ## About Uroxatral (alfuzosin) **Uroxatral** is an alpha-blocker specifically approved for men with BPH, a common condition where the prostate gland enlarges and presses on the urethra, causing urinary problems like weak stream, frequent urination (especially at night), urgency, or difficulty starting urination. It does not shrink the prostate but helps manage symptoms effectively. Typical dosage is 10 mg once daily, taken with food to enhance absorption and reduce side effects. Common side effects include dizziness, headache, fatigue, and low blood pressure—especially when standing up quickly (orthostatic hypotension). Always follow your doctor's instructions, and contact them if you experience serious issues like fainting, chest pain, or allergic reactions (rash, swelling).[1][5] OPAF, sponsored by Otsuka (the manufacturer), provides this program to bridge access gaps for those facing financial barriers to vital medications like Uroxatral. Medications are shipped directly to approved patients at no cost, helping maintain treatment continuity.[1][3] ## Who Qualifies for OPAF? The program targets **uninsured or underinsured patients** who cannot afford their Otsuka medications, including Uroxatral. While specific income thresholds (like Federal Poverty Level percentages) are not publicly detailed, eligibility focuses on financial need demonstrated through household income proof. Patients must reside in the U.S., have a valid prescription, and not be enrolled in government programs that fully cover the drug in ways conflicting with OPAF rules. Healthcare providers play a key role in confirming medical necessity.[3][5][6] ## Income Eligibility Breakdown OPAF requires proof of household income for all contributing members to assess need. No fixed Federal Poverty Level (FPL) cutoff is specified, making it flexible but documentation-heavy. Submit one of these per household contributor: | Document Type | Examples | Notes | |---------------|----------|-------| | **Tax Returns** | Most recent federal tax return (e.g., 1040 form) | Preferred for accuracy[6] | | **Pay Stubs** | Last 4-6 weeks | W-2 or employer letter also accepted | | **Benefit Letters** | SSI, SSDI, unemployment statements | Shows total household income | | **Other** | Bank statements, pension docs | Must cover full household[3][6] | **Tip**: Include everyone in your household (spouse, dependents) and their incomes. Incomplete docs delay approval.[6] ## Insurance Requirements **Uninsured or underinsured patients** qualify—meaning no prescription coverage or coverage that doesn't pay for Uroxatral. Disclose all insurance details on the form: - Private insurance with high copays/deductibles? - Medicare/Medicaid? (May disqualify if fully covered) - No insurance? OPAF verifies payer info. If insured but underinsured (e.g., copay >$50/month), you may still qualify. Government-insured patients often need prescriber confirmation of coverage gaps.[4][8] ## Step-by-Step Application Process Work with your doctor—**they submit most sections** for best results.[8] Here's how: 1. **Discuss with Your Doctor**: Confirm Uroxatral is right for you. Ask them to complete the prescriber section (signature, diagnosis, dosage).[1][2] 2. **Gather Documents**: - Proof of income (see table above). - Photo ID (SSN card, driver's license, passport, etc.).[6] - Insurance cards/details (if any). - Contact info for you and alternate (caregiver/guardian).[8] 3. **Choose Application Method** (multiple options): - **Online (Fastest)**: Visit www.otsukapatientassistance.com, use OPAF Care Connect Portal. Upload everything—takes minutes.[1][3] - **Download Paper Form**: From patient-forms page, fill out, then fax (1-844-727-6274) or mail (Otsuka Patient Assistance Foundation, PO Box 4530, Chesterfield, MO 63006).[3][4] - Doctor can submit via portal, fax, or mail on your behalf.[2] 4. **Sign Authorizations**: Consent to share health/financial info (HIPAA-compliant, confidential).[4][6] 5. **Submit**: Doctor faxes/emails/uploads. Call 1-855-727-6274 (Mon-Fri, 8AM-6PM ET) for help.[3] **Pro Tip**: Complete apps process faster. Missing info causes delays![3][8] ## Timeline and Delivery - **Processing**: Up to **3 business days** for eligibility (online/paper). Some older forms note 48 hours or 5 days—aim for 2-5 days total.[3][6][7] - **Notification**: Mailed to you and doctor. If approved, meds ship **directly to your home** from a specialty pharmacy. First shipment often within 1-2 weeks.[8][9] - **Supply Duration**: Typically 1-3 months per approval; reapply as needed.[9] Track status by calling the helpline. ## Alternatives if Denied or Ineligible - **Appeal**: Contact OPAF (1-855-727-6274) to fix issues (e.g., missing docs). Resubmit promptly.[9] - **Other Assistance**: Check Partnership for Prescription Assistance (PPARx.org), NeedyMeds.org, or RxAssist.org for Uroxatral coupons/savings cards. - **Generic alfuzosin**: Cheaper option; ask your doctor. - **Manufacturer Copay Cards**: Otsuka may offer via patient-services.otsuka-us.com (1-833-468-7852).[10] - **State Programs**: Medicaid, 340B clinics, or community health centers. - **No biosimilars** for Uroxatral (small molecule drug).[5] ## Important Disclaimer This guide is for informational purposes only and based on publicly available OPAF details as of 2025. Eligibility, processes, and contacts can change—**always verify at www.otsukapatientassistance.com or by calling 1-855-727-6274**. OPAF decisions are final; this is not medical/financial advice. Consult your healthcare provider before starting/stopping Uroxatral. Otsuka does not control OPAF distributions. Report side effects to Otsuka at 1-800-438-9927 or FDA (1-800-FDA-1088).[2][3] **Word count: 1028**

Program information last verified: March 30, 2026